Intrinsiqs

Is AbbVie Inc. overvalued?

AbbVie Inc. (ABBV) — key valuation metrics and fundamentals.

No verdict
Price
$264.40
Fair value
—
Current P/E
—
Normal P/E
20.9
Market cap
$467.14B
Dividend yield
2.6%
Return on equity
-136.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ABBV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonMRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedNVS Novartis AG